TY - JOUR
T1 - Metabolic and contractile changes in fast and slow muscles of the cat after glucocorticoid-induced atrophy
AU - Gardiner, P. F.
AU - Botterman, B. R.
AU - Eldred, E.
AU - Simpson, D. R.
AU - Edgerton, V. R.
N1 - Funding Information:
The susceptibility of fast-and slow-twitch hind limb muscles to glucocorticoid-induced atrophy was investigated in adult male cats treated for 10 to 14 days with triamcinolone (4 mg/kg/day), using several histochemical, biochemical, and functional indices. After treatment, muscle weight loss in the fast-twitch muscles (medial gastrocnemius and vastus medialis) occurred to a greater extent than in the slow-twitch muscles (soleus and vastus intermedius), with the latter muscles decreasing in weight proportional to the body weight. Fast-twitch glycolytic (FG) fibers responded with similar degrees of atrophy in the muscles examined; however, slow-twitch oxidative (SO) and fast-twitch oxidative glycolytic (FOG) fibers atrophied more in the fast-twitch compared to the slow-twitch muscles. Phosphofructokinase and NADP+-linked isocitrate dehydrogenase specific activities decreased similarly in the fast-twitch muscles, while no change occurred in the slow-twitch muscles. Functionally, the soleus and medial gastrocnemius remained unchanged in abilities to generate tension tetanically, when this was expressed per unit muscle mass or per unit contractile protein. As a result of the treatment, however, the medial gastrocnemius fatigued faster in response to repetitive stimulation in the glucocorticoid-treated animals. The results suggest that the response of muscle to glucocorticoid-induced Abbreviations : FG-fast-twitch glycolytic ; SO-slow-twitch oxidative ; FOG-.-fast-twitch oxidative glycolytic; ATPase-adenosine triphosphatase ; NADH-nicotinamide adenines dinucleotide ; PFK-phosphofructokinase ; ICDH-isocitrate dehydrogenase ; SDH-succinic dehydrogenase. l Supported by U.S. Public Health Service grant NS 11950, and a Biomedical Research Support Grant. The current address of Dr. Gardiner is CEPSUM, University of Montreal, Montreal, P.Q., H3C 3J7. The current address of Dr. Botterman is Department of Physiology, College of Medicine, University of Arizona, Tucson, Arizona 85721. Triamcinolone was supplied through the courtesy of Lederle Laboratories, Pearl River, New York, who also suggested use of the vehicle used.
PY - 1978/10
Y1 - 1978/10
N2 - The susceptibility of fast- and slow-twitch hind limb muscles to glucocorticoid-induced atrophy was investigated in adult male cats treated for 10 to 14 days with triamcinolone (4 mg/kg/day), using several histochemical, biochemical, and functional indices. After treatment, muscle weight loss in the fast-twitch muscles (medial gastrocnemius and vastus medialis) occurred to a greater extent than in the slow-twitch muscles (soleus and vastus intermedius), with the latter muscles decreasing in weight proportional to the body weight. Fast-twitch glycolytic (FG) fibers responded with similar degrees of atrophy in the muscles examined; however, slow-twitch oxidative (SO) and fast-twitch oxidative glycolytic (FOG) fibers atrophied more in the fast-twitch compared to the slow-twitch muscles. Phosphofructokinase and NADP+-linked isocitrate dehydrogenase specific activities decreased similarly in the fast-twitch muscles, while no change occurred in the slow-twitch muscles. Functionally, the soleus and medial gastrocnemius remained unchanged in abilities to generate tension tetanically, when this was expressed per unit muscle mass or per unit contractile protein. As a result of the treatment, however, the medial gastrocnemius fatigued faster in response to repetitive stimulation in the glucocorticoid-treated animals. The results suggest that the response of muscle to glucocorticoid-induced atrophy is not regulated by the primary metabolic pathways used for energy production. The differences in response of the SO and FOG fiber types in fast- versus slow-twitch muscles suggest basic differences in metabolic and activity profiles of the same fiber types in different muscles, which may influence susceptibility to atrophy.
AB - The susceptibility of fast- and slow-twitch hind limb muscles to glucocorticoid-induced atrophy was investigated in adult male cats treated for 10 to 14 days with triamcinolone (4 mg/kg/day), using several histochemical, biochemical, and functional indices. After treatment, muscle weight loss in the fast-twitch muscles (medial gastrocnemius and vastus medialis) occurred to a greater extent than in the slow-twitch muscles (soleus and vastus intermedius), with the latter muscles decreasing in weight proportional to the body weight. Fast-twitch glycolytic (FG) fibers responded with similar degrees of atrophy in the muscles examined; however, slow-twitch oxidative (SO) and fast-twitch oxidative glycolytic (FOG) fibers atrophied more in the fast-twitch compared to the slow-twitch muscles. Phosphofructokinase and NADP+-linked isocitrate dehydrogenase specific activities decreased similarly in the fast-twitch muscles, while no change occurred in the slow-twitch muscles. Functionally, the soleus and medial gastrocnemius remained unchanged in abilities to generate tension tetanically, when this was expressed per unit muscle mass or per unit contractile protein. As a result of the treatment, however, the medial gastrocnemius fatigued faster in response to repetitive stimulation in the glucocorticoid-treated animals. The results suggest that the response of muscle to glucocorticoid-induced atrophy is not regulated by the primary metabolic pathways used for energy production. The differences in response of the SO and FOG fiber types in fast- versus slow-twitch muscles suggest basic differences in metabolic and activity profiles of the same fiber types in different muscles, which may influence susceptibility to atrophy.
UR - http://www.scopus.com/inward/record.url?scp=0018084234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018084234&partnerID=8YFLogxK
U2 - 10.1016/0014-4886(78)90054-7
DO - 10.1016/0014-4886(78)90054-7
M3 - Article
C2 - 153233
AN - SCOPUS:0018084234
SN - 0014-4886
VL - 62
SP - 241
EP - 255
JO - Experimental Neurology
JF - Experimental Neurology
IS - 1
ER -